Company Filing History:

8 out of 163

Incyte Genomics, Inc.

Incyte Pharmaceuticals, Inc.

patents

Years Active: 2000-2006

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7112426 - Human cAMP-dependent protein kinase beta-catalytic subunit (2006-09-26),

2. 7105315 - Transmembrane protein differentially expressed in cancer (2006-09-12),

3. 6808895 - DNA encoding oxidoreductase and polypeptide encoded thereby (2004-10-26),

4. 6750027 - Human ubiquitin-conjugating enzyme homologs (2004-06-15),

5. 6558935 - Human transferase proteins (2003-05-06),

6. 6372431 - Mammalian toxicological response markers (2002-04-16),

7. 6277574 - Genes associated with diseases of the kidney (2001-08-21),

8. 6277568 - Nucleic acids encoding human ubiquitin-conjugating enzyme homologs (2001-08-21),

9. 6264947 - Protein kinase homologs (2001-07-24),

10. 6262247 - Polycyclic aromatic hydrocarbon induced molecules (2001-07-17),

11. 6222027 - Molecules expressed in hippocampus (2001-04-24),

12. 6013455 - Protein kinase homologs (2000-01-11),

Title: Yalda Azimzai: Innovator in Protein Kinase Research

Introduction

Yalda Azimzai is a prominent inventor based in Castro Valley, California. She has made significant contributions to the field of biotechnology, particularly in the area of protein kinases. With a total of 12 patents to her name, her work has the potential to impact various medical applications.

Latest Patents

Among her latest patents is the invention related to the human cAMP-dependent protein kinase beta-catalytic subunit. This invention provides human kinases (PKIN) and polynucleotides that identify and encode PKIN. It also includes expression vectors, host cells, antibodies, agonists, and antagonists. Furthermore, the invention outlines methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PKIN. Another notable patent is for a transmembrane protein that is differentially expressed in cancer. This invention offers a transmembrane protein that can be used in various methods to diagnose, stage, treat, or monitor the treatment of neoplastic disorders.

Career Highlights

Yalda has worked with notable companies such as Incyte Genomics, Inc. and Incyte Corporation. Her experience in these organizations has allowed her to develop her expertise in the field of biotechnology and contribute to groundbreaking research.

Collaborations

Yalda has collaborated with several professionals in her field, including Henry Yue and Mariah R Baughn. These collaborations have further enriched her research and innovation efforts.

Conclusion

Yalda Azimzai is a distinguished inventor whose work in protein kinase research has led to significant advancements in biotechnology. Her patents reflect her commitment to improving medical diagnostics and treatments.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.